-
Kenya's economy faces climate change risks: World Bank
-
Meta partners with news outlets to expand AI content
-
Penguins queue in Paris zoo for their bird flu jabs
-
Sri Lanka issues fresh landslide warnings as toll nears 500
-
Stocks, dollar rise before key US inflation data
-
After wins abroad, Syria leader must gain trust at home
-
Markets rise ahead of US data, expected Fed rate cut
-
German factory orders rise more than expected
-
Flooding kills two as Vietnam hit by dozens of landslides
-
Italy to open Europe's first marine sanctuary for dolphins
-
Hong Kong university suspends student union after calls for fire justice
-
Asian markets rise ahead of US data, expected Fed rate cut
-
Georgia's street dogs stir affection, fear, national debate
-
Pandas and ping-pong: Macron ending China visit on lighter note
-
TikTok to comply with 'upsetting' Australian under-16 ban
-
Pentagon endorses Australia submarine pact
-
Softbank's Son says super AI could make humans like fish, win Nobel Prize
-
OpenAI strikes deal on US$4.6 bn AI centre in Australia
-
Rains hamper Sri Lanka cleanup after deadly floods
-
Unchecked mining waste taints DR Congo communities
-
Asian markets mixed ahead of US data, expected Fed rate cut
-
French almond makers revive traditions to counter US dominance
-
Aid cuts causing 'tragic' rise in child deaths, Bill Gates tells AFP
-
Abortion in Afghanistan: 'My mother crushed my stomach with a stone'
-
How to Manage ESG Data Efficiently
-
Mixed day for US equities as Japan's Nikkei rallies
-
To counter climate denial, UN scientists must be 'clear' about human role: IPCC chief
-
Facebook 'supreme court' admits 'frustrations' in 5 years of work
-
South Africa says wants equal treatment, after US G20 exclusion
-
One in three French Muslims say suffer discrimination: report
-
Microsoft faces complaint in EU over Israeli surveillance data
-
Milan-Cortina organisers rush to ready venues as Olympic flame arrives in Italy
-
Truth commission urges Finland to rectify Sami injustices
-
Stocks rise eyeing series of US rate cuts
-
Italy sweatshop probe snares more luxury brands
-
EU hits Meta with antitrust probe over WhatsApp AI features
-
Russia's Putin heads to India for defence, trade talks
-
South Africa telecoms giant Vodacom to take control of Kenya's Safaricom
-
Markets mixed as traders struggle to hold Fed cut rally
-
Asian markets mixed as traders struggle to hold Fed cut rally
-
In Turkey, ancient carved faces shed new light on Neolithic society
-
Asian markets stumble as traders struggle to hold Fed cut rally
-
Nintendo launches long-awaited 'Metroid Prime 4' sci-fi blaster
-
Trump scraps Biden's fuel-economy standards, sparking climate outcry
-
US stocks rise as weak jobs data boosts rate cut odds
-
Poor hiring data points to US economic weakness
-
Germany to host 2029 women's Euros
-
Satellite surge threatens space telescopes, astronomers warn
-
Greek govt warns farmers not to escalate subsidy protest
-
EU agrees deal to ban Russian gas by end of 2027
No link between paracetamol and autism, major review finds
There is no clear link between pregnant women taking the common painkiller paracetamol and autism in their children, despite repeated claims otherwise by Donald Trump, according to the most comprehensive review of the existing evidence published Monday.
In September, the US president sparked outrage among the medical community by claiming that paracetamol -- also known as acetaminophen -- was associated with higher rates of autism.
Trump urged pregnant women to "tough it out" rather than take paracetamol, comments which health researchers warned could scare women off their safest option to treat pain -- and risked further stigmatising autistic people.
The World Health Organization has emphasised that there is no robust evidence showing that paracetamol -- which is the main ingredient in massively popular painkillers such as Tylenol and Panadol -- causes autism.
On Monday, an "umbrella" review of all the scientific research yet conducted on the subject was published in the British medical journal BMJ.
"Existing evidence does not show a clear link between in utero exposure to paracetamol and autism and ADHD in offspring," the UK-lead team of researchers wrote in the review.
There have been several previous studies which suggested a possible link between paracetamol and autism or attention deficit hyperactivity disorder (ADHD).
However the quality of those studies was "low to critically low", the review said, partly because they did not take adequate steps to rule out potentially misleading factors such as whether autism runs in the family.
These controversial previous studies also could not establish exactly how paracetamol might cause autism.
The umbrella review called for better research, pointing out that there has been a "historical and ongoing underinvestment in women's health research".
- Confirmation -
Several researchers praised the new study.
Dimitrios Siassakos, professor in obstetrics and gynaecology at University College London, said the review "confirms what experts around the globe have been saying".
"Autistic and neurodivergent people are more likely to experience chronic pain, and they are also much more likely to have neurodivergent children -- but paracetamol doesn't cause neurodivergence," said Steven Kapp of the University of Portsmouth.
"As a researcher and autistic person with ADHD, I think we should not be trying to prevent neurodivergence anyway, but make life better for neurodivergent people," he added.
Beyond paracetamol, Trump and his vaccine-sceptic Health Secretary Robert F. Kennedy Jr have repeatedly made unfounded claims about autism, including that there is an "epidemic" of cases.
However experts maintain that the recent increase in autism rates is due to improved, broadened diagnosis methods along with growing awareness.
H.Cho--CPN